MORF Company Profile and Key Details
Morphic Holding, Inc.
MORF Stock Price Chart
Stock Price Today
Morphic Holding, Inc. (MORF) stock surged +0.04%, trading at $56.99 on NASDAQ, up from the previous close of $56.97. The stock opened at $56.97, fluctuating between $56.97 and $57.00 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children's Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Company Information
| Employees | 128 |
| Beta | 1.49 |
| Sales or Revenue | $521.00K |
| 5Y Sales Change% | -0.916% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Morphic Holding, Inc. (NASDAQ: MORF) stock price is $56.99 in the last trading session. During the trading session, MORF stock reached the peak price of $57.00 while $56.97 was the lowest point it dropped to. The percentage change in MORF stock occurred in the recent session was 0.04% while the dollar amount for the price change in MORF stock was $0.02.
The NASDAQ listed MORF is part of Biotechnology industry that operates in the broader Healthcare sector. Morphic Holding, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Marc Schegerin M.B.A., M.D.
Chief Financial Officer & Chief Operating Officer
Mr. William D. DeVaul Esq.
Gen. Counsel & Sec.
Dr. Praveen P. Tipirneni M.D.
Chief Executive Officer, MD & Director
Dr. Blaise Lippa Ph.D.
Chief Scientific Officer
Dr. Bruce N. Rogers Ph.D.
Pres
Dr. Timothy A. Springer Ph.D.
Founder, Independent Director & Member of Scientific Advisory Board
Mr. Aaron Pelta
Senior Vice President of Bus. & Corporation Devel.
Mr. Robert E. Farrell Jr., CPA, CPA
Senior Vice President of Fin. & Chief Accounting Officer
Mr. Robert E. Farrell Jr., C.P.A., CPA
Senior Vice President of Fin. & Chief Accounting Officer
Ms. Joanne Gibbons
Senior Vice President of Regulatory Affairs
MORF's closing price is 194.6% higher than its 52-week low of $19.35 where as its distance from 52-week high of $57.00 is -0.02%.
Number of MORF employees currently stands at 128.
Official Website of MORF is: https://www.morphictx.com
MORF could be contacted at phone 781 996 0955 and can also be accessed through its website. MORF operates from 35 Gatehouse Drive, A2, Waltham, MA 02451, United States.
MORF stock volume for the day was 1.74M shares. The average number of MORF shares traded daily for last 3 months was 2.45M.
The market value of MORF currently stands at $2.86B with its latest stock price at $56.99 and 50.22M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com